|
MRS2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.88178419700125E-16 |
| Normal-vs-Stage2 |
1.385810E-04 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
4.773800E-02 |
| Stage1-vs-Stage3 |
7.339000E-03 |
| Stage1-vs-Stage4 |
1.078980E-03 |
| Stage2-vs-Stage3 |
9.578900E-04 |
| Stage2-vs-Stage4 |
2.224800E-04 |
| Stage3-vs-Stage4 |
4.249400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.6114000002736E-07 |
| Normal-vs-Asian |
1.37779999631604E-08 |
| Caucasian-vs-AfricanAmerican |
4.182200E-01 |
| Caucasian-vs-Asian |
3.549900E-02 |
| AfricanAmerican-vs-Asian |
5.598600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.22568621918617E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
6.399400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63546953757532E-12 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
5.53810330927718E-11 |
| Normal-vs-Age(81-100Yrs) |
1.880400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.139600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.283600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.513400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.014600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.761800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.739200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.771100E-04 |
| Classical-VS-Follicular |
4.69830000016103E-07 |
| Classical-VS-Other |
9.408000E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
9.14219810965733E-11 |
| Tall-VS-Other |
1.305240E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
9.733700E-02 |
| Follicular-VS-Normal |
6.215600E-04 |
| Other-VS-Normal |
2.018700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.16666701141821E-12 |
| Normal-vs-N1 |
8.88178419700125E-16 |
| N0-vs-N1 |
3.923300E-03 |
|
|
